2- https://doi.org/10.1016/j.lanwpc.2023.100777
Efficacy of antivirals and mRNA vaccination against an XBF clinical isolate
Translate Article 
Efficacy of antivirals and mRNA vaccination against an XBF clinical isolate
- Discussion
- 21
- 10.1016/s0140-6736(21)02020-1
- Jan 1, 2021
- Lancet (London, England)
SARS-CoV-2's origin should be investigated worldwide for pandemic prevention
- Discussion
- 63
- 10.1016/j.jpeds.2020.06.057
- Jun 22, 2020
- The Journal of Pediatrics
Multisystem Inflammatory Syndrome in Children and Kawasaki Disease: Two Different Illnesses with Overlapping Clinical Features
- Research Article
- 5
- 10.1016/j.ajodo.2020.08.010
- Sep 21, 2020
- American Journal of Orthodontics and Dentofacial Orthopedics
COVID-19: What do we know?
- Research Article
- 56
- 10.1016/j.celrep.2022.110336
- Jan 20, 2022
- Cell Reports
SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people
- Discussion
- 10
- 10.1016/s2213-2600(21)00538-5
- Dec 1, 2021
- The Lancet Respiratory Medicine
Does the rise in seasonal respiratory viruses foreshadow the return of invasive pneumococcal disease this winter?
- Discussion
- 33
- 10.1016/s1473-3099(23)00289-x
- Jun 5, 2023
- The Lancet. Infectious Diseases
Neutralising immunity to omicron sublineages BQ.1.1, XBB, and XBB.1.5 in healthy adults is boosted by bivalent BA.1-containing mRNA vaccination and previous Omicron infection
- Discussion
- 6
- 10.1016/j.jinf.2022.06.021
- Jun 26, 2022
- The Journal of Infection
SNX27-mediated endocytic recycling of GLUT1 is suppressed by SARS-CoV-2 spike, possibly explaining neuromuscular disorders in patients with COVID-19
- Research Article
- 178
- 10.1016/j.jhepr.2020.100169
- Aug 4, 2020
- JHEP Reports
Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic.
- Front Matter
- 25
- 10.1378/chest.126.3.670
- Sep 1, 2004
- Chest
Treatment of Severe Acute Respiratory Syndrome
- Front Matter
- 114
- 10.1053/j.ajkd.2021.06.004
- Jun 25, 2021
- American Journal of Kidney Diseases
De Novo and Relapsing Glomerular Diseases After COVID-19 Vaccination: What Do We Know So Far?
- Research Article
- 17
- 10.1016/j.ejim.2021.10.006
- Oct 14, 2021
- European Journal of Internal Medicine
Electrocardiographic features of patients with COVID-19: One year of unexpected manifestations
- Discussion
- 1
- 10.1053/j.jvca.2020.08.041
- Aug 26, 2020
- Journal of Cardiothoracic and Vascular Anesthesia
Testing the Asymptomatic Pre-Surgical Population for Severe Acute Respiratory Syndrome Coronavirus 2
- Supplementary Content
- 248
- 10.1016/s2665-9913(20)30120-x
- May 20, 2020
- The Lancet Rheumatology
The immunology of COVID-19: is immune modulation an option for treatment?
- Discussion
- 10.1016/j.ejim.2023.06.014
- Jun 16, 2023
- European Journal of Internal Medicine
Safety of SARS-CoV-2 mRNA vaccines and effects of immunosuppressive drugs on adverse reactions in patients with rheumatic diseases
- Research Article
- 190
- 10.1016/s2665-9913(20)30420-3
- Jan 7, 2021
- The Lancet. Rheumatology
COVID-19 vasculitis and novel vasculitis mimics.
Save Important notes in documents
Highlight text to save as a note, or write notes directly
You can also access these Documents in Paperpal, our AI writing tool
Powered by our AI Writing Assistant
